Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Multi-center, open-label, multiple dose study in mild to moderate asthmatics (with IgE/body weight combinations above that in the SmPC dosing table) to determine safety, tolerability, pharmacokinetics, and pharmacodynamics of omalizumab https://kusajili.com:443/Trial/xMIWDJiug0-0hP20aBXQrg%24multi-center-open-label-multiple-dose-study-in-mild-to-moderate-asthmatics-with-igebody-weight-combinations-above-that-in-the-s
I have read and accept the terms of use of the site and the Privacy Policy
Send your message